1887

Chapter 9 : Epidemiology of Bloodstream Infections

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Epidemiology of Bloodstream Infections, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819828/9781555819811_Chap09-1.gif /docserver/preview/fulltext/10.1128/9781555819828/9781555819811_Chap09-2.gif

Abstract:

The detection of microorganisms in the setting of bloodstream infection is one of the most important functions of the clinical microbiology laboratory. A number of advances and practice changes in health care, including hematopoietic stem cell transplantation (HSCT) and solid organ transplantation (SOT) and resulting immunosuppressive regimens, as well as the aging population, emergence of antimicrobial resistance, and increased use of invasive procedures in health care settings (as well as improvements in blood culture methods), have resulted in changing epidemiology of bloodstream infections over the past 4 decades. This chapter will discuss trends in the epidemiology of positive blood cultures.

Citation: McMullen A, Wilen C, Burnham C. 2017. Epidemiology of Bloodstream Infections, p 163-181. In Dunne, Jr. W, Burnham C (ed), The Dark Art of Blood Cultures. ASM Press, Washington, DC. doi: 10.1128/9781555819811.ch9
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1
Figure 1

Overview of bacteria most commonly associated with bloodstream infections.

Citation: McMullen A, Wilen C, Burnham C. 2017. Epidemiology of Bloodstream Infections, p 163-181. In Dunne, Jr. W, Burnham C (ed), The Dark Art of Blood Cultures. ASM Press, Washington, DC. doi: 10.1128/9781555819811.ch9
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

The organisms most frequently recovered from blood cultures, 1975 to 2015. ( ) Weinstein et al., 1983; ( ) Cockerill et al., 1997; ( ) Weinstein et al., 1997; ( ) Wisplinghoff et al., 2004; ( ) Biedenbach et al., 2004; ( ) Pien et al., 2010.

Citation: McMullen A, Wilen C, Burnham C. 2017. Epidemiology of Bloodstream Infections, p 163-181. In Dunne, Jr. W, Burnham C (ed), The Dark Art of Blood Cultures. ASM Press, Washington, DC. doi: 10.1128/9781555819811.ch9
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 3
Figure 3

Overview of fungi most commonly associated with bloodstream infections.

Citation: McMullen A, Wilen C, Burnham C. 2017. Epidemiology of Bloodstream Infections, p 163-181. In Dunne, Jr. W, Burnham C (ed), The Dark Art of Blood Cultures. ASM Press, Washington, DC. doi: 10.1128/9781555819811.ch9
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555819828.chap9
1. Weinstein MP,, Reller LB,, Murphy JR,, Lichtenstein KA, Laboratory and Epidemiologic Observations. 1983. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. I. Laboratory and epidemiologic observations. Rev Infect Dis 5:3553.
2. Cockerill FR III,, Hughes JG,, Vetter EA,, Mueller RA,, Weaver AL,, Ilstrup DM,, Rosenblatt JE,, Wilson WR. 1997. Analysis of 281,797 consecutive blood cultures performed over an eight-year period: trends in microorganisms isolated and the value of anaerobic culture of blood. Clin Infect Dis 24:403418.
3. Weinstein MP,, Towns ML,, Quartey SM,, Mirrett S,, Reimer LG,, Parmigiani G,, Reller LB. 1997. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 24:584602.
4. Wisplinghoff H,, Bischoff T,, Tallent SM,, Seifert H,, Wenzel RP,, Edmond MB. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39:309317.
5. Biedenbach DJ,, Moet GJ,, Jones RN. 2004. Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997-2002). Diagn Microbiol Infect Dis 50:5969.
6. Pien BC,, Sundaram P,, Raoof N,, Costa SF,, Mirrett S,, Woods CW,, Reller LB,, Weinstein MP. 2010. The clinical and prognostic importance of positive blood cultures in adults. Am J Med 123:819828.
7. Myint TT,, Madhava H,, Balmer P,, Christopoulou D,, Attal S,, Menegas D,, Sprenger R,, Bonnet E. 2013. The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review. Adv Ther 30:127151.
8. Vena A,, Muñoz P,, Alcalá L,, Fernandez-Cruz A,, Sanchez C,, Valerio M,, Bouza E. 2015. Are incidence and epidemiology of anaerobic bacteremia really changing? Eur J Clin Microbiol Infect Dis 34:16211629.
9. Ng LS,, Kwang LL,, Rao S,, Tan TY. 2015. Anaerobic bacteraemia revisited: species and susceptibilities. Ann Acad Med Singapore 44:1318.
10. Blairon L,, De Gheldre Y,, Delaere B,, Sonet A,, Bosly A,, Glupczynski Y. 2006. A 62-month retrospective epidemiological survey of anaerobic bacteraemia in a university hospital. Clin Microbiol Infect 12:527532.
11. De Keukeleire S,, Wybo I,, Naessens A,, Echahidi F,, Van der Beken M,, Vandoorslaer K,, Vermeulen S,, Piérard D. 2016. Anaerobic bacteraemia: a 10-year retrospective epidemiological survey. Anaerobe 39:5459.
12. Fenner L,, Widmer AF,, Straub C,, Frei R. 2008. Is the incidence of anaerobic bacteremia decreasing? Analysis of 114,000 blood cultures over a ten-year period. J Clin Microbiol 46:24322434.
13. Dorsher CW,, Rosenblatt JE,, Wilson WR,, Ilstrup DM. 1991. Anaerobic bacteremia: decreasing rate over a 15-year period. Rev Infect Dis 13:633636.
14. Lombardi DP,, Engleberg NC. 1992. Anaerobic bacteremia: incidence, patient characteristics, and clinical significance. Am J Med 92:5360.
15. Murray PR,, Traynor P,, Hopson D. 1992. Critical assessment of blood culture techniques: analysis of recovery of obligate and facultative anaerobes, strict aerobic bacteria, and fungi in aerobic and anaerobic blood culture bottles. J Clin Microbiol 30:14621468.
16. Goldstein EJ. 1996. Anaerobic bacteremia. Clin Infect Dis 23(Suppl 1):S97S101.
17. Muñoz P,, Cruz AF,, Rodríguez-Créixems M,, Bouza E. 2008. Gram-negative bloodstream infections. Int J Antimicrob Agents 32(Suppl 1):S10S14.
18. Rodríguez-Créixems M,, Alcalá L,, Muñoz P,, Cercenado E,, Vicente T,, Bouza E. 2008. Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006. Medicine (Baltimore) 87:234249.
19. Karchmer AW. 2009. Bloodstream infections: the problem and the challenge. Int J Antimicrob Agents 34(Suppl 4):S2S4.
20. Lamas CC,, Fournier PE,, Zappa M,, Brandão TJ,, Januário-da-Silva CA,, Correia MG,, Barbosa GI,, Golebiovski WF,, Weksler C,, Lepidi H,, Raoult D. 2016. Diagnosis of blood culture-negative endocarditis and clinical comparison between blood culture-negative and blood culture-positive cases. Infection 44:459466.
21. Tattevin P,, Watt G,, Revest M,, Arvieux C,, Fournier PE. 2015. Update on blood culture-negative endocarditis. Med Mal Infect 45:18.
22. Baron EJ,, Miller JM,, Weinstein MP,, Richter SS,, Gilligan PH,, Thomson RB Jr,, Bourbeau P,, Carroll KC,, Kehl SC,, Dunne WM,, Robinson-Dunn B,, Schwartzman JD,, Chapin KC,, Snyder JW,, Forbes BA,, Patel R,, Rosenblatt JE,, Pritt BS. 2013. Executive summary: a guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis 57:485488.
23. Weinstein MP,, Mirrett S,, Wilson ML,, Reimer LG,, Reller LB. 1994. Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic BacT/Alert blood culture bottles. J Clin Microbiol 32:21032106.
24. Biondi E,, Evans R,, Mischler M,, Bendel-Stenzel M,, Horstmann S,, Lee V,, Aldag J,, Gigliotti F. 2013. Epidemiology of bacteremia in febrile infants in the United States. Pediatrics 132:990996.
25. Mischler M,, Ryan MS,, Leyenaar JK,, Markowsky A,, Seppa M,, Wood K,, Ren J,, Asche C,, Gigliotti F,, Biondi E. 2015. Epidemiology of bacteremia in previously healthy febrile infants: a follow-up study. Hosp Pediatr 5:293300.
26. Leazer R,, Perkins AM,, Shomaker K,, Fine B. 2016. A meta-analysis of the rates of Listeria monocytogenes and Enterococcus in febrile infants. Hosp Pediatr 6:187195.
27. Sutter D,, Stagliano D,, Braun L,, Williams F,, Arnold J,, Ottolini M,, Epstein J. 2008. Polymicrobial bloodstream infection in pediatric patients: risk factors, microbiology, and antimicrobial management. Pediatr Infect Dis J 27:400405.
28. Swinne D,, Nolard N,, Van Rooij P,, Detandt M. 2009. Bloodstream yeast infections: a 15-month survey. Epidemiol Infect 137:10371040.
29. Lagrou K,, Verhaegen J,, Peetermans WE,, De Rijdt T,, Maertens J,, Van Wijngaerden E. 2007. Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species. Eur J Clin Microbiol Infect Dis 26:541547.
30. Shorr AF,, Gupta V,, Sun X,, Johannes RS,, Spalding J,, Tabak YP. 2009. Burden of early-onset candidemia: analysis of culture-positive bloodstream infections from a large U.S. database. Crit Care Med 37:25192526, quiz 2535.
31. Geha DJ,, Roberts GD. 1994. Laboratory detection of fungemia. Clin Lab Med 14:8397.
32. Miceli MH,, Díaz JA,, Lee SA. 2011. Emerging opportunistic yeast infections. Lancet Infect Dis 11:142151.
33. Pfaller MA,, Diekema DJ. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20:133163.
34. Slavin MA, Australian Mycology Interest Group. 2002. The epidemiology of candidaemia and mould infections in Australia. J Antimicrob Chemother 49(Suppl 1):36.
35. Bonfietti LX,, Martins MA,, Szeszs MW,, Pukiskas SB,, Purisco SU,, Pimentel FC,, Pereira GH,, Silva DC,, Oliveira L,, Melhem MS. 2012. Prevalence, distribution and antifungal susceptibility profiles of Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis bloodstream isolates. J Med Microbiol 61:10031008.
36. Richardson M,, Lass-Flörl C. 2008. Changing epidemiology of systemic fungal infections. Clin Microbiol Infect 14(Suppl 4):524.
37. Gupta A,, Gupta A,, Varma A. 2015. Candida glabrata candidemia: an emerging threat in critically ill patients. Indian J Crit Care Med 19:151154.
38. Fernández-Ruiz M,, Puig-Asensio M,, Guinea J,, Almirante B,, Padilla B,, Almela M,, Díaz-Martín A,, Rodríguez-Baño J,, Cuenca-Estrella M,, Aguado JM, CANDIPOP Project, GEIH-GEMICOMED (SEIMC), REIPI. 2015. Candida tropicalis bloodstream infection: incidence, risk factors and outcome in a population-based surveillance. J Infect 71:385394.
39. Borman AM,, Szekely A,, Johnson EM. 16 February 2017. Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins. Med Mycol doi:10.1093/mmy/myw147.
40. Lockhart SR,, Etienne KA,, Vallabhaneni S,, Farooqi J,, Chowdhary A,, Govender NP,, Colombo AL,, Calvo B,, Cuomo CA,, Desjardins CA,, Berkow EL,, Castanheira M,, Magobo RE,, Jabeen K,, Asghar RJ,, Meis JF,, Jackson B,, Chiller T,, Litvintseva AP. 2017. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 64:134140.
41. Vallabhaneni S,, Kallen A,, Tsay S,, Chow N,, Welsh R,, Kerins J,, Kemble SK,, Pacilli M,, Black SR,, Landon E,, Ridgway J,, Palmore TN,, Zelzany A,, Adams EH,, Quinn M,, Chaturvedi S,, Greenko J,, Fernandez R,, Southwick K,, Furuya EY,, Calfee DP,, Hamula C,, Patel G,, Barrett P, MSD,, Lafaro P,, Berkow EL,, Moulton-Meissner H,, Noble-Wang J,, Fagan RP,, Jackson BR,, Lockhart SR,, Litvintseva AP,, Chiller TM. 2016. Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrug-resistant fungus - United States, May 2013-August 2016. MMWR Morb Mortal Wkly Rep 65:12341237.
42. Pfaller MA,, Moet GJ,, Messer SA,, Jones RN,, Castanheira M. 2011. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009. Antimicrob Agents Chemother 55:561566.
43. Zilberberg MD,, Shorr AF,, Kollef MH. 2008. Secular trends in candidemia-related hospitalization in the United States, 2000-2005. Infect Control Hosp Epidemiol 29:978980.
44. Gulia J,, Aryal S,, Saadlla H,, Shorr AF. 2010. Health care-associated candidemia--a distinct entity? J Hosp Med 5:298301.
45. Tortorano AM,, Kibbler C,, Peman J,, Bernhardt H,, Klingspor L,, Grillot R. 2006. Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 27:359366.
46. Hamula CL,, Hughes K,, Fisher BT,, Zaoutis TE,, Singh IR,, Velegraki A. 2016. T2Candida provides rapid and accurate species identification in pediatric cases of candidemia. Am J Clin Pathol 145:858861.
47. Pfaller MA,, Wolk DM,, Lowery TJ. 2016. T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis. Future Microbiol 11:103117.
48. Mylonakis E,, Clancy CJ,, Ostrosky-Zeichner L,, Garey KW,, Alangaden GJ,, Vazquez JA,, Groeger JS,, Judson MA,, Vinagre YM,, Heard SO,, Zervou FN,, Zacharioudakis IM,, Kontoyiannis DP,, Pappas PG. 2015. T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial. Clin Infect Dis 60:892899.
49. Schuetz AN. 2013. Invasive fungal infections: biomarkers and molecular approaches to diagnosis. Clin Lab Med 33:505525.
50. Pulimood S,, Ganesan L,, Alangaden G,, Chandrasekar P. 2002. Polymicrobial candidemia. Diagn Microbiol Infect Dis 44:353357.
51. Guerra-Romero L,, Telenti A,, Thompson RL,, Roberts GD. 1989. Polymicrobial fungemia: microbiology, clinical features, and significance. Rev Infect Dis 11:208212.
52. Klotz SA,, Chasin BS,, Powell B,, Gaur NK,, Lipke PN. 2007. Polymicrobial bloodstream infections involving Candida species: analysis of patients and review of the literature. Diagn Microbiol Infect Dis 59:401406.
53. Arendrup MC,, Boekhout T,, Akova M,, Meis JF,, Cornely OA,, Lortholary O, European Society of Clinical Microbiology and Infectious Diseases Fungal Infection Study Group, European Confederation of Medical Mycology. 2014. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect 20(Suppl 3):7698.
54. Liao Y,, Lu X,, Yang S,, Luo Y,, Chen Q,, Yang R. 2015. Epidemiology and outcome of trichosporon fungemia: a review of 185 reported cases from 1975 to 2014. Open Forum Infect Dis 2:ofv141.
55. Siddiqui W,, Ahmed Y,, Albrecht H,, Weissman S. 12 December 2014. Pseudozyma spp catheter-associated blood stream infection, an emerging pathogen and brief literature review. BMJ Case Rep 2014. doi:10.1136/bcr-2014-206369.
56. Pande A,, Non LR,, Romee R,, Santos CA. 18 January 2017. Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center. Transpl Infect Dis doi:10.1111/tid.12664.
57. Sanz Alonso MA,, Jarque Ramos I,, Salavert Lletí M,, Pemán J. 2006. Epidemiology of invasive fungal infections due to Aspergillus spp. and Zygomycetes. Clin Microbiol Infect 12:26.
58. Pagano L,, Caira M,, Candoni A,, Offidani M,, Fianchi L,, Martino B,, Pastore D,, Picardi M,, Bonini A,, Chierichini A,, Fanci R,, Caramatti C,, Invernizzi R,, Mattei D,, Mitra ME,, Melillo L,, Aversa F,, Van Lint MT,, Falcucci P,, Valentini CG,, Girmenia C,, Nosari A. 2006. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 91:10681075.
59. Park BJ,, Pappas PG,, Wannemuehler KA,, Alexander BD,, Anaissie EJ,, Andes DR,, Baddley JW,, Brown JM,, Brumble LM,, Freifeld AG,, Hadley S,, Herwaldt L,, Ito JI,, Kauffman CA,, Lyon GM,, Marr KA,, Morrison VA,, Papanicolaou G,, Patterson TF,, Perl TM,, Schuster MG,, Walker R,, Wingard JR,, Walsh TJ,, Kontoyiannis DP. 2011. Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001-2006. Emerg Infect Dis 17:18551864.
60. Dabas Y,, Bakhshi S,, Xess I. 2016. Fatal cases of bloodstream infection by Fusarium solani and review of published literature. Mycopathologia 181:291296.
61. Campigotto A,, Richardson SE,, Sebert M,, McElvania TeKippe E,, Chakravarty A,, Doern CD. 2016. Low utility of pediatric isolator blood culture system for detection of fungemia in children: a 10-year review. J Clin Microbiol 54:22842287.
62. Kauffman CA. 2007. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 20:115132.
63. Saccente M,, Woods GL. 2010. Clinical and laboratory update on blastomycosis. Clin Microbiol Rev 23:367381.
64. Roberts GD,, Washington JA II. 1975. Detection of fungi in blood cultures. J Clin Microbiol 1:309310.
65. Graybill JR. 1988. Histoplasmosis and AIDS. J Infect Dis 158:623626.
66. Paya CV,, Roberts GD,, Cockerill FR III. 1987. Laboratory methods for the diagnosis of disseminated histoplasmosis: clinical importance of the lysis-centrifugation blood culture technique. Mayo Clin Proc 62:480485.
67. Ampel NM,, Ryan KJ,, Carry PJ,, Wieden MA,, Schifman RB. 1986. Fungemia due to Coccidioides immitis. An analysis of 16 episodes in 15 patients and a review of the literature. Medicine (Baltimore) 65:312321.
68. El Helou G,, Viola GM,, Hachem R,, Han XY,, Raad II. 2013. Rapidly growing mycobacterial bloodstream infections. Lancet Infect Dis 13:166174.
69. Al Yazidi LS,, Marais BJ,, Hazelton B,, Outhred A,, Kesson A. 2017. Nontuberculous mycobacteria in children - a focus on bloodstream infections. Pediatr Infect Dis J 36:374378.
70. Hawkins C,, Qi C,, Warren J,, Stosor V. 2008. Catheter-related bloodstream infections caused by rapidly growing nontuberculous mycobacteria: a case series including rare species. Diagn Microbiol Infect Dis 61:187191.
71. van Duin D,, Goldfarb J,, Schmitt SK,, Tomford JW,, Tuohy MJ,, Hall GS. 2010. Nontuberculous mycobacterial blood stream and cardiac infections in patients without HIV infection. Diagn Microbiol Infect Dis 67:286290.
72. Zambrano MM,, Kolter R. 2005. Mycobacterial biofilms: a greasy way to hold it together. Cell 123:762764.
73. Oplustil CP,, Leite OH,, Oliveira MS,, Sinto SI,, Uip DE,, Boulos M,, Mendes CF. 2001. Detection of mycobacteria in the bloodstream of patients with acquired immunodeficiency syndrome in a university hospital in Brazil. Braz J Infect Dis 5:252259.
74. Pedro-Botet ML,, Mòdol JM,, Vallés X,, Romeu J,, Sopena N,, Giménez M,, Tor J,, Clotet B,, Sabrià M. 2002. Changes in bloodstream infections in HIV-positive patients in a university hospital in Spain (1995-1997). Int J Infect Dis 6:1722.
75. Pierce M,, Crampton S,, Henry D,, Heifets L,, LaMarca A,, Montecalvo M,, Wormser GP,, Jablonowski H,, Jemsek J,, Cynamon M,, Yangco BG,, Notario G,, Craft JC. 1996. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med 335:384391.
76. Sommerstein R,, Schreiber PW,, Diekema DJ,, Edmond MB,, Hasse B,, Marschall J,, Sax H. 2017. Mycobacterium chimaera outbreak associated with heater-cooler devices: piecing the puzzle together. Infect Control Hosp Epidemiol 38:103108.
77. Kohler P,, Kuster SP,, Bloemberg G,, Schulthess B,, Frank M,, Tanner FC,, Rössle M,, Böni C,, Falk V,, Wilhelm MJ,, Sommerstein R,, Achermann Y,, Ten Oever J,, Debast SB,, Wolfhagen MJ,, Brandon Bravo Bruinsma GJ,, Vos MC,, Bogers A,, Serr A,, Beyersdorf F,, Sax H,, Böttger EC,, Weber R,, van Ingen J,, Wagner D,, Hasse B. 2015. Healthcare-associated prosthetic heart valve, aortic vascular graft, and disseminated Mycobacterium chimaera infections subsequent to open heart surgery. Eur Heart J 36:27452753.
78. Sax H,, Bloemberg G,, Hasse B,, Sommerstein R,, Kohler P,, Achermann Y,, Rössle M,, Falk V,, Kuster SP,, Böttger EC,, Weber R. 2015. Prolonged outbreak of Mycobacterium chimaera infection after open-chest heart surgery. Clin Infect Dis 61:6775.
79. Williamson D,, Howden B,, Stinear T. 2017. Mycobacterium chimaera spread from heating and cooling units in heart surgery. N Engl J Med 376:600602.
80. Svensson E,, Jensen ET,, Rasmussen EM,, Folkvardsen DB,, Norman A,, Lillebaek T. 2017. Mycobacterium chimaera in heater-cooler units in Denmark related to isolates from the United States and United Kingdom. Emerg Infect Dis 23:507509.
81. Pavlinac PB,, Lokken EM,, Walson JL,, Richardson BA,, Crump JA,, John-Stewart GC. 2016. Mycobacterium tuberculosis bacteremia in adults and children: a systematic review and meta-analysis. Int J Tuberc Lung Dis 20:895902.
82. Jacob ST,, Pavlinac PB,, Nakiyingi L,, Banura P,, Baeten JM,, Morgan K,, Magaret A,, Manabe Y,, Reynolds SJ,, Liles WC,, Wald A,, Joloba ML,, Mayanja-Kizza H,, Scheld WM. 2013. Mycobacterium tuberculosis bacteremia in a cohort of hiv-infected patients hospitalized with severe sepsis in uganda–high frequency, low clinical suspicion [corrected] and derivation of a clinical prediction score. PLoS One 8:e70305.
83. Hall KK,, Lyman JA. 2006. Updated review of blood culture contamination. Clin Microbiol Rev 19:788802.
84. Dawson S. 2014. Blood culture contaminants. J Hosp Infect 87:110.
85. CLSI. 2007. Principles and Procedures for Blood Cultures; Approved Guideline., CLSI document M47-A ed. CLSI, Wayne, PA.
86. Weinstein MP. 2003. Blood culture contamination: persisting problems and partial progress. J Clin Microbiol 41:22752278.
87. Schifman RB,, Strand CL,, Meier FA,, Howanitz PJ. 1998. Blood culture contamination: a College of American Pathologists Q-probes study involving 640 institutions and 497134 specimens from adult patients. Arch Pathol Lab Med 122:216221.

Tables

Generic image for table
Table 1

Microorganisms isolated from positive blood cultures at a tertiary care academic medical center, 2014 to 2015

Citation: McMullen A, Wilen C, Burnham C. 2017. Epidemiology of Bloodstream Infections, p 163-181. In Dunne, Jr. W, Burnham C (ed), The Dark Art of Blood Cultures. ASM Press, Washington, DC. doi: 10.1128/9781555819811.ch9

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error